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Introduction
Members of the TGF-b family of growth factors exhibit various functions throughout development (Chang et al., 2002; Parker et al., 2004) . They can be subdivided into at least two subgroups, the Bone Morphogenetic Proteins (BMP) and the Activin/TGF-b subgroup (Newfeld et al., 1999) . All members form dimers through an intermolecular disulfide bond. The ligand dimers initiate signaling by binding to tetrameric complexes of two type I and two type II receptors (Yamashita et al., 1994) . Ligand-receptor complex formation outside the cell leads to an intracellular phosphorylation cascade. When in proximity to type II receptors, type I receptors are phosphorylated at a glycine/serine-rich domain (Wieser et al., 1995; Wrana et al., 1994) . This modification results in conformational change and activation of the type I receptor kinase domains. The target of activated type I receptors are SMAD transcription factors. After phosphorylation at the last two 0925-4773/$ -see front matter Published by Elsevier Ireland Ltd. doi:10.1016/j.mod.2010.04.001 conserved serine residues at the C-terminus, they form trimeric complexes and translocate into the nucleus, where they join other transcription factors to regulate the expression of specific target genes (Chacko et al., 2001; Kretzschmar et al., 1997; Liu et al., 1997; Persson et al., 1998; Souchelnytskyi et al., 1997) .
Drosophila encodes seven members of the TGF-b family (Parker et al., 2004) . Four belong to the Activin/TGF-b group, which is believed to use the type I receptor Baboon (BABO) for downstream signaling. In contrast, the three BMP-type ligands, Decapentaplegic (DPP), Glass Bottom Boat (GBB), and Screw (SCW), signal through the two type I receptors Thick Veins (TKV) and Saxophone (SAX), which activate Mothers against DPP (MAD). While several studies have indicated that TKV is essential for growth and patterning in various tissues, SAX appears to function as a modulator of TKV signaling (Bangi and Wharton, 2006; Singer et al., 1997) . Rescue experiments have shown that low numbers of sax mutants can be rescued by increased expression of TKV, indicating that SAX is not absolutely necessary for viability (Brummel et al., 1994) . Genetic interactions in the wing suggested that DPP primarily binds to TKV and GBB to SAX (Haerry et al., 1998) . However, subsequent studies have shown that TKV is required for GBB signaling (Bangi and Wharton, 2006; Khalsa et al., 1998) . Since excess amounts of SAX inhibit rather than enhance GBB signaling, it was proposed that SAX might exhibit high affinity for GBB but lack signaling activity. Two reports have found that during embryonic and wing development SAX can synergistically enhance low levels of TKV signaling (Haerry et al., 1998; Neul and Ferguson, 1998) . Up until now, the mechanism of this synergistic interaction remained a mystery.
The focus of this report was to analyze, how the distinct extracellular and intracellular domains of TKV and SAX affect ligand binding and downstream signaling and thus contribute to gradient formation. Co-immunoprecipitation experiments show that the two type I receptors not only form homodimers but also heterodimers, which unlike homodimers can bind both DPP and GBB. Inside the cell, MAD phosphorylated by activated SAX and certain mutant forms of activated TKV is unable to alter the expression of downstream genes in wing discs, suggesting that MAD requires an additional activation step that does not occur in tetrameric complexes that contain SAX homodimers. Co-expression of activated SAX can complement inactive mutant forms of activated TKV, indicating that the activity of SAX is higher in heterodimers with TKV than in homodimers. Differences in signaling between SAX and TKV can be localized to an area that has been show to interfere with functional tetrameric complex formation between TGF-b type I receptors and type II receptors in vertebrate cells (Weis-Garcia and Massague, 1996) . The finding that the type II receptor PUNT but not activated forms of SAX can further enhance the activity of the pseudo-activated MAD-SDVD, which cannot be phosphorylated at the C-terminus, supports a model, where SMAD activation requires the presence of type II receptors and a second phosphorylation step. Taken together, the results show that SAX-TKV heterodimers play an important role in gradient formation by extending DPP diffusion and allowing robust signaling of GBB through functional tetrameric complexes with type II receptors.
Results

SAX and TKV can form heterodimers
Previous experiments suggested that GBB might signal through tetrameric complexes that contain type II receptors and heterodimers of SAX and TKV (Bangi and Wharton, 2006) . To investigate, whether heterodimers can form, C-terminally HA-and FLAG-tagged forms of SAX, TKV, BABO, and the unrelated transmembrane protein Drosophila Syndecan (SDC, G and H isoforms) were cloned in pAcpA under the control of the actin5C regulatory sequences. After co-transfection of these constructs into Schneider 2 (S2) cells, extracts were used to perform co-immunoprecipitation experiments. It was found that all type I receptors can form complexes with each other (Fig. 1, lanes 2-8) . Based on the intensities of the precipitated protein bands, it appears that all type I receptors form homodimers and heterodimers with similar affinities. In the control experiments, HAtagged forms of TKV or SAX are not precipitated with FLAG-SDC ( Fig. 1 , lanes 11 and 12). In addition to the fulllength proteins, smaller HA-tagged bands are detected that correspond to receptor forms cleaved within the extracellular domains. Constructs that lack the extracellular domains are also efficiently precipitated (data not shown), suggesting that dimer formation between type I receptors primarily depends on the intracellular domains. In wing discs, TKV is expressed in a reverse gradient (de Celis, 1997; Tanimoto et al., 2000) . Thus, TKV homodimers are lowest at the anterior-posterior compartment boundary (Fig. 1, solid blue) . Homodimers of the uniformly expressed SAX are highest, where TKV levels are low ( Fig. 1 solid red) , whereas heterodimers of TKV and SAX are lowest in this area and rise with increasing levels of TKV (Fig. 1, green) .
2.2.
DPP and GBB bind to heterodimers of TKV and SAX Genetic interactions suggested that DPP primarily binds to TKV and GBB to SAX (Haerry et al., 1998) . To investigate their binding preferences, HA and FLAG-tags were inserted between the processing site and the first cysteine of the mature domains of DPP and GBB. When expressed in wings and other tissues, tagged forms of DPP and GBB generate phenotypes identical to non-tagged ligands, indicating that the tags do not interfere with their function (data not shown). The processed secreted forms of DPP and GBB migrate at a higher molecular weight than predicted based on amino acid composition (22 and 15 kDa, respectively), most likely due to glycosylation. After secretion from tissue culture cells, DPP-HA strongly binds to cells transfected with FLAG-tagged TKV but not SAX (Fig. 2, lanes 1-3) . On the other hand, GBB-HA is only precipitated by FLAG-tagged SAX but not TKV (Fig. 2 , lanes 7-9). Only in the presence of non-tagged TKV or SAX are small amounts of DPP and GBB able to bind to SAX and TKV, respectively (Fig. 2 , lanes 4 and 10). Neither DPP nor GBB interacts with the FLAG-tagged Activin type I receptor BABO in this assay (Fig. 2, lanes 6, 12, and 13) . These results show that DPP primarily binds to TKV and GBB to SAX, while both ligands exhibit small affinities for heterodimers of TKV and SAX.
2.3.
Differences between SAX and TKV signaling in wings
Several reports have shown that TKV and SAX exhibit different roles during wing development. While clones of sax primarily affect the fate of wing margin cells (Singer et al., 1997) , clones of tkv do not compete well and can only be recovered in a minute background . While there are significant differences within the extracellular domains, the intracellular domains of type I receptors are very similar. The three-dimensional structure of the TGF-b type I receptor (TbRI) has been resolved and can be used to model type I receptor dimers (Huse et al., 1999) . Several studies have identified specific functional regions within the intracellular domain. The glycine and serine rich GS-box is located close to the membrane (Fig. 3A) . Phosphorylation of multiple serine residues within this region by type II receptors is necessary to change the conformation of the kinase domain into an active configuration . The L45 loop, located beyond the GS-box ( Fig. 3A and B) , was shown to be involved in SMAD selection and binding (Chen et al., 1998; Persson et al., 1998) . The E6 loop, which is located between the L45 loop and close to the catalytic region, has been implicated in type I receptor dimerization (Huse et al., 1999) . In the dimer model, the E6 loop is located close to the C-terminal alpha helix of the second subunit (Fig. 3C) . Previous experiments have shown that the intracellular domains of TKV and SAX exhibit dramatically different signaling abilities in wings (Haerry et al., 1998) . Compared to wild type wings and discs ( Fig. 4A-C) , ubiquitous expression of two transgenes that encode constitutively activated forms of SAX (SAX-Q263D, SAX-A) with the wing driver A9-GAL4 does not affect the expression of the downstream genes optomotor blind (omb, bifid) and spalt (sal) and only causes the formation of some ectopic vein tissue (Haerry et al., 1998) . In contrast, ubiquitous expression of an activated form of TKV (TKV1-Q199D, TKV1-A) results in ectopic expression of omb and sal (Haerry et al., 1998; Lecuit et al., 1996; Muller et al., 2003; Nellen et al., 1996) . Adult wings derived from these discs are highly pigmented due to intervein to vein transformation and smaller due to apoptosis (Gesualdi and Haerry, 2007; Haerry et al., 1998) . Since A9-GAL4 expression persists longer in the dorsal than the ventral compartment, the wings are curled and blistered due to dorsal over-proliferation.
Sequence comparison of the intracellular domains of TKV and SAX reveals that SAX lacks two conserved threonines. The first residue, K382 is located in the E6 loop and corresponds to the location of T318 in TKV1. The second residue, P543 is located in front of the C-terminal helix at the equivalent position of T485 in TKV1. To study the relevance of the unique E6 loop residue in SAX, lysine 382 in SAX-A was mutated into threonine. This single amino acid change dramatically increased the signaling activity of SAX-A. Compared to SAX-A (Fig. 4D-F) , SAX-A-K382T is able to ectopically activate omb and sal in wing discs and to disrupt vein patterning of adult wings (Fig. 4G-I) . The finding that a K382A mutation does not alter the activity of SAX-A indicates that any substi- Fig. 1 -Type I receptors form homodimers and heterodimers. Type I receptors that are tagged with HA and FLAG at the Ctermini are co-transfected and immunoprecipitated with anti-FLAG beads. All proteins migrate at a higher molecular weight than expected, most likely due to glycosylation within the extracellular domains. The expected sizes of the full-length proteins are 57 kDa for TKV1, 62 kDa for SAX, 65 kDa for BABOa, and 67 kDa for BABOb, 39 kDa for SDC-G, and 21 kDa for SDC-H. In addition to the full-length proteins, smaller bands corresponding to receptor forms cleaved within the extracellular domain are also present. tution other than the conserved threonine results in weak signaling of SAX-A (Fig. S1C) . In contrast to SAX-A, the reverse substitution TKV1-A-T318K does not affect the ectopic activation of sal when expressed in wing discs (Fig. S1A ), resulting in a wing phenotype similar to TKV1-A ( Fig. S1B and 4J ). The finding that ubiquitously expressed TKV1-T318K transgenes can efficiently rescue tkv mutants further indicates that the conserved threonine is not as critical for the activity of TKV as it is for SAX.
Previously, a mutation in the E6 loop of TbRI at the position equivalent to G381 in SAX and G317 in TKV was shown to obstruct the interaction with type II receptors (Weis-Garcia and Massague, 1996) . The substitution of the small glycine with the large negatively charged aspartic acid prevents type II receptors from phosphorylating and activating TbRI-G322D. However, co-transfection with a kinase-inactive TbRI is able to complement this activation-defective G322D mutant receptor. To investigate similarities to this mutation, K382 in SAX-A and T318 in TKV1-A were substituted with aspartic acids. When expressed with A9-GAL4 in wings, SAX-A-K382D and TKV1-A-T318D did not result in ectopic vein formation but loss of veins similar to expression of receptors with intracellular truncations that cause dominant-negative phenotypes due to altered receptor stoichiometry and sequestration of ligands. Like expression of wild type or dominant-negative SAX (Haerry et al., 1998) , SAX-A-K382D affects the formation of longitudinal vein 2 (L2) and in L5, which is shorter and does not reach the margin (Fig. S1E ). In comparison, wings that express TKV1-A-T318D show defects in L2 and L5 and lose most of L4, which merges with L5 ( Fig. 4M) . In contrast to TKV1-A, expression of TKV1-A-T318D does not expand the domains of the downstream genes omb and sal ( Fig. 4N and O). Animals that express TKV1-A-T485D with a substitution of the conserved threonine in front of the C-terminal helix exhibit identical wing phenotypes (compare Fig. 4 P-M). These results show that the T318D and T485D mutations in TKV1-A do not activate downstream genes and cause loss-of-function phenotypes due to ligand sequestration.
In wild type discs, high levels of C-terminally phosphorylated MAD (P-MAD) are detected with an anti-P-MAD antibody in the nuclei of cells located within a narrow stripe along the , the GS-box (GS), the phosphate binding loop (P), the L45 SMAD binding region, the E6 loop, the catalytic region of the kinase domain, and the conserved threonine at the position correlating to T485 in TKV and P543 in SAX. (B and C) Three-dimensional structure of the TbRI intracellular domain (Huse et al., 1999) . G322 interacts with the C-terminal helix and is located next to the conserved T323 located at the equivalent position of T318 in TKV1 and K382 in SAX.
expression of dpp (Fig. 4Q ). Although wing discs that ubiquitously express SAX-A do not ectopically activate omb and sal ( Fig. 4E and F), they show an expansion of the stripe of nuclear P-MAD (Fig. 4R ). In comparison, P-MAD is found in the nuclei of all cells of wing discs that express TKV1-A (Fig. 4S) . Surprisingly, P-MAD is similarly expanded in discs that express the ''inactive'' TKV1-A-T318D (Fig. 4T ). Although the ectopic MAD phosphorylated by TKV1-A-T318D localizes to the nucleus ( Fig. 4U and V), it fails to expand the domains of the downstream genes omb and sal ( Fig. 4N and O). Taken to-gether, these results indicate that C-terminal phosphorylation of MAD is sufficient for nuclear localization but not for the transcriptional regulation of downstream genes.
C-terminal phosphorylation of MAD by TKV and SAX in S2 cells
To quantitatively compare the MAD-phosphorylation activity of wild type and E6 mutant forms of TKV1-A and SAX-A, equal amounts of DNA constructs were co-transfected with FLAG-tagged MAD in tissue culture cells. After 4 days, phosphorylation of MAD was analyzed on Western blots with anti-P-MAD antibodies. In contrast to FLAG-MAD alone, cotransfection of TKV1-A with MAD results in a robust signal of P-MAD (Fig. 5, lane 2) . Based on luminosity and number of pixels, TKV1-A-T318K and the ''inactive'' TKV1-A-T318D show phosphorylation levels equivalent to those of TKV1-A (Fig. 5, lanes 2-4) . Compared to TKV1-A, the levels of MAD phosphorylated by SAX-A and the E6 loop mutant SAX-A-K382D are approximately 10 times lower (Fig. 5 , lanes 5 and 7). Compared to SAX-A, the activity of SAX-A-K382T is approximately 3-fold higher (Fig. 5 , lane 6), but still three times lower than TKV1-A or TKV1-A-T318D (Fig. 5 , lanes 2 and 4). Since the activity of the TKV1-A-T318D, which cannot activate of omb and sal ( Fig. 4N and O) , is higher than SAX-A-K382T, which can ectopically induce expression of the two downstream genes ( Fig. 4H and I ), the levels of C-terminal MAD phosphorylation cannot be the only criterion that determines the threshold for downstream gene activation.
2.5.
The type II receptor PUT can enhance the activity of MAD The ability of TKV1-A to activate the downstream genes omb and sal is abolished by the E6 loop mutation T318D, resulting in loss-of-function wing phenotypes. The single T485D change in front of the C-terminal helix similarly diminishes the activity of the activated receptor. It is unlikely that the two residues are involved in SMAD binding, since they are located far from the L45 loop (Huse et al., 1999; Persson et al., 1998) . Although SAX-A-K382T increases the levels of P-MAD by approximately 3-fold, the finding that the TKV1-A-T318D substitution does not change the amounts of P-MAD suggests that the altered residue does not directly control the level of the catalytic reaction. The E6 loop residue is located close to the C-terminal helix of the other subunit (Fig. 3C) , suggesting that it could affect type I receptor dimerization. Since the formation of SAX and TKV1-A-T318D homodimers is comparable to wild type or activated forms of TKV, it appears that the E6 loop mutations do not quantitatively change the level of receptor dimerization (Fig. 1, data not shown) . The finding that an aspartic acid residue next to TKV1-A-T318D can interfere with type II receptor complex formation and prevent TbRII from phosphorylating TbRI suggests that E6 loop mutations may induce structural changes in type I receptor dimers that facilitate or impair their ability to bind type II receptor dimers. A three-dimensional model of a tetrameric complex of type I and type II receptors would be useful to assess the importance of these residues in complex formation. In the absence of such a model, the data suggests that amino acid variations in the E6 loop and other areas of SAX prevent SAX homodimers to form functional complexes with the type II receptors PUNT (PUT) and Wishful Thinking (WIT). Similarly, T318D and T485D could prevent the formation of active complexes with type II receptors. Since homodimers of SAX-A and TKV1-A-T318D are able to phosphorylate MAD but MAD phosphorylated by these receptors fails to activate downstream genes, it appears that the complete activation of MAD requires a second step in addition to C-terminal phosphorylation. If such an additional step requires the presence of type II receptors that exhibit serine/threonine kinase activity, it is possible that type II receptors directly phosphorylate SMADs in a functional complex with type I receptors. Alternatively, type II receptors could induce a structural change in type I receptor dimers that results in a second phosphorylation step of SMADs by type I receptors, which is prevented in 
complexes that contain SAX-A or TKV1-A-T318D homodimers. In both scenarios, MAD can only be fully activated by tetrameric complexes that contain TKV homodimer or SAX-TKV heterodimer but not SAX homodimers.
To test this model and investigate a possible role of type II receptors in MAD activation, SAX-A and the type II receptor PUT were co-expressed with the pseudo-activated MAD-SDVD. As previously shown, transgenes that express MAD-SDVD, which cannot be phosphorylated at the C-terminus, are able to promote downstream signaling (Gesualdi and Haerry, 2007 ). It appears that the SDVD activation does not fully mimic normal C-terminal phosphorylation, since activation of downstream target genes requires the expression of multiple copies of MAD-SDVD transgenes. Compared to wings that ubiquitously express SAX-A or MAD-SDVD ( Fig. 6A and   B ), combined expression does not significantly enhance the wing defects of the individual transgenes (Fig. 6C) , indicating that MAD-SDVD is a not a substrate for SAX-A. In contrast, coexpression of PUT with MAD-SDVD clearly enhances the defects in wing growth and patterning caused by the single transgenes (compare Fig. 6E-B and D) . Like expression of TKV1-A (Fig. 4J) , the wings are highly pigmented due to intervein to vein transformation, smaller due to apoptosis, and blistered due to distinct dorsal and ventral proliferation rates. While expression of PUT or a single copy of MAD-SDVD is not sufficient to ectopically activate sal in wing discs ( Fig. 6F and G), combined expression of PUT and MAD-SDVD results in ectopic expression of sal (Fig. 6H) . Consistent with the notion that normal C-terminal phosphorylation of MAD is more potent than the pseudo-activation in MAD-SDVD, co-expression of PUT with MAD results in more severe wing defects than with MAD-SDVD (Fig. S1F) . In summary, the finding that PUT but not SAX-A is able to further activate MAD-SDVD, which cannot be phosphorylated at the C-terminus, supports the model that activation of SMADs involves the presence of type II receptors and a second step in addition to C-terminal phosphorylation.
2.6.
Mutant type I receptors are still able to bind to type II receptors Previously, it was shown that the G322D mutation in TbRI prevents TbRII from phosphorylating TbRI (Weis-Garcia and Massague, 1996). It was not determined, however, whether this mutation is severe enough to prevent complex formation between type I and type II receptors altogether. Thus, co-immunoprecipitation experiments with epitope tagged receptors were performed to examine, whether homodimers of SAX-A and TKV1-A-T318D are able to forms complexes with the type II receptor PUT. The results show that TKV1-A and TKV1-A-T318D bind equally well to PUT (Fig. 7, lanes 2 and 3) . SAX-A is also efficiently precipitated in presence of PUT, and the SAX-A-K382T mutant form, which compared to SAX-A can activate downstream target genes ( Fig. 4H and I) , is not coimmunoprecipitated at a significant higher level (Fig. 7 , lanes 5 and 6). Taken together, these results indicate that homodimers of SAX-A and TKV1-A-T318D can form tetrameric complexes with inactive three-dimensional configurations that are unable to properly activate MAD and downstream target genes.
SAX-A can enhance the activity of TKV receptor mutants
Homodimers of SAX-A can phosphorylate MAD at the C-terminus (Figs. 4R and 5) but exhibit low signaling activity in vivo (Fig. 4D-F) . The result that SAX homodimers cannot further activate MAD-SDVD could be explained by a model, where homodimers of SAX do not form active complexes with PUT. The model could also explain the previous finding that high levels of SAX-A can synergistically enhance signaling of low amounts of TKV-A (Haerry et al., 1998; Neul and Ferguson, 1998) . If the presence of TKV-A allows SAX-A to form functional complexes of with type II receptors, the activity of SAX-A would be significantly higher in SAX-TKV heterodimers than in homodimers. In the case of synergistic interaction, only a fraction of the low amounts of TKV-A exist as active homodimers, while large numbers of TKV-A form Fig. 7 -E6 loop mutant type I receptors are able to form complexes with type II receptors. Co-immunoprecipitation experiments show that, compared to activated receptors, the T318D and K382T substitutions in the E6 loops of TKV-A and SAX-A, respectively, do not quantitatively change the interactions between the type I receptors and the type II receptor PUT (compare lanes 2 and 3, and lanes 5 and 6). Again, smaller receptor forms that are cleaved within the extracellular domain are also precipitated. non-activated complexes with endogenous receptors. Doubling the amount of TKV-A only slightly increases the number of active homodimers. If, however, high levels of SAX-A are co-expressed, a large amount of TKV-A receptors will form heterodimers with SAX-A that can activate MAD and downstream genes. To test this model, SAX-A was co-expressed with various mutant forms of TKV. Expression of the dominant-negative TKV-A-DGS that lacks the GS-box results in a loss-of-function phenotype with reduced growth and the loss of L3 and L4, which merge with L2 and L5, respectively (Fig. 8A) . Co-expression of SAX-A with this inactive form of TKV-A dramatically enhances signaling of the individual receptors and causes gain-of-function wing phenotypes similar to TKV1-A (compare Figs. 8B-4J ). The synergy is even stronger in wings that co-express SAX-A with the E6 loop mutant TKV1-A-T318D (compare Figs. 8C-4D and M) . This result is analogous to the complementation between a kinase-mutant form and the inactive E6 mutant TbRI-G322D that allows activation of the E6 mutant form by type II receptors (WeisGarcia and Massague, 1996) . The combined expression of the in vivo inactive SAX-A-K382D and TKV1-A-T318D also results in a robust complementation with a slightly weaker gain-of-function wing phenotype (compare Fig. 8D to Fig. S1E and 4M ). This result indicates that the E6 substitutions in SAX-A and TKV1-A only interfere with the formation of active receptor complexes in homodimers but not heterodimers. In comparison, the ability of SAX-A to complement the C-terminal helix mutant TKV1-A-T485D is significantly lower, since wings that express the two transgenes show relatively weak gain-of-function phenotypes (Fig. 8E) . The E6 substitution in SAX-A-K382D almost completely abolishes any synergistic interaction with TKV1-A-T485D, resulting in a loss-offunction phenotype similar to expression of TKV1-A-T485D alone (compare Fig. 8F to Fig. 4P ). Almost identical phenotypes are seen with SAX-A or SAX-A-K382D with the double mutant TKV1-A-T318D-T485D (compare Fig. 8G and H-E and F). Taken together, these results strongly support a model, where SAX-A and mutant forms of TKV1-A complement each other in heterodimers, allowing SAX-A to contribute to signaling in functional tetrameric complexes with type II receptors.
Discussion
The findings of this report reveal that dimer combinations of the BMP type I receptors TKV and SAX play an important role in ligand binding, downstream gene activation, and hence the formation of the BMP morphogen gradient. In wing discs, the concentration of SAX homodimers, which bind GBB but not DPP, is the highest at the anterior-posterior compartment boundary. Since SAX exhibits little signaling activity, GBB does not contribute much to the BMP morphogen gradient in this area. Homodimers of SAX-A can phosphorylate MAD at C-terminal serine residues, but are unable to activate downstream genes like omb and sal. Since PUT but not homodimers of SAX-A can enhance the pseudo-activated MAD-SDVD, C-terminal phosphorylation of MAD is evidently not sufficient for activation of downstream genes. This result suggests that the complete activation of SMADs requires type II receptors and a second phosphorylation step. In contrast to homodimers, SAX-TKV heterodimers can bind both DPP and GBB. Signaling of SAX-A is strongly enhanced in heterodimers with TKV1-A. As signaling of DPP secreted from the anteriorposterior boundary decreases with distance, the contribution to the activity gradient by the uniformly expressed GBB rises with increasing level of SAX-TKV heterodimers. Finally, high levels of TKV are only expressed far from the DPP expressing cells. Since DPP levels are low and GBB does not efficiently bind to TKV, homodimers of TKV contribute little to the activity gradient.
Gradient formation by different receptor complexes
Wing patterning requires a DPP diffusion gradient (Lecuit et al., 1996; Nellen et al., 1996) . However, a second ligand, GBB, is required to augment DPP signaling for the activation of downstream genes (Haerry et al., 1998) . As discussed below, SAX in heterodimers with TKV plays an important role in extending the activity gradient by facilitating DPP diffusion and assisting in GBB signaling. Along the gradient, signaling levels are determined by a combination of three parameters: concentration of ligands and receptors (A), binding affinities of ligands to receptors (B), and intracellular signaling activities of the receptors (C).
(A) Whereas GBB is expressed almost ubiquitously, DPP is expressed and secreted from cells at the anterior-posterior compartment boundary. Within the expression domain of omb, TKV is expressed at very low levels. It has been shown that TKV forms an inverse gradient with the lowest expression at the compartment boundary (de Celis, 1997; Tanimoto et al., 2000) . In contrast to TKV, SAX is expressed uniformly throughout the disc (Brummel et al., 1994; Penton et al., 1994) . Although the absolute concentrations of TKV and SAX are not known, the formation of heterodimers of TKV and SAX is expected to follow the expression pattern of TKV (Fig. 1, right bottom panel) . While homodimers of SAX are highest at the anterior-posterior compartment boundary, where the concentration of TKV is the least, heterodimers and TKV homodimers are the lowest in this area and increase with distance. (B) The binding studies in this report corroborate the previous model that TKV and SAX are the high affinity receptors for DPP and GBB, respectively (Haerry et al., 1998) . They also substantiate the notion that GBB can signal through a heterodimer of SAX and TKV (Bangi and Wharton, 2006) . TKV is expressed at very low levels in the area where DPP is expressed. It has been shown that increased levels of TKV inhibit DPP diffusion, disrupt patterning, and reduce growth (Haerry et al., 1998; Lecuit and Cohen, 1998) . TKV homodimers mainly form where TKV levels are high far from the DPP expressing cells. If DPP primarily signals through SAX-TKV heterodimers, which have a low affinity for DPP, heterodimers extend the limit of DPP diffusion. The levels of SAX homodimers, which have a strong affinity for GBB, are highest along the anterior-posterior compartment boundary where TKV levels are the lowest. As SAX-TKV heterodimers rise with distance from the compartment boundary, GBB signaling through heterodimers increases as well. The finding that ubiquitous low-level expression of tkv can rescue a small number of sax mutants suggested that GBB can bind to TKV homodimers (Brummel et al., 1994) . However, since the interaction between GBB and TKV is below detection levels in immunoprecipitation assays (Fig. 2B) , the binding of GBB to TKV homodimers has to be considerably lower than to SAX-TKV heterodimers. (C) Signaling assays show that the intracellular domains of TKV-A and SAX-A differ in their ability to phosphorylate MAD (Figs. 4 and 5) . In tissue culture cells, phosphorylation of MAD by homodimers of TKV1-A is approximately ten times higher than by SAX-A (Fig. 5) . However, as discussed later, the actual signaling of SAX homodimers is most likely even lower, since MAD phosphorylated by SAX-A is unable to ectopically activate downstream genes in wing discs (Fig. 4R , E and F). The finding that the wing phenotype of SAX-A can dramatically be enhanced by co-expression of mutant forms of TKV1-A with low or no activity indicates that SAX-A is significantly more active in heterodimers with TKV-A than in homodimers ( Fig. 8B and C) . To discuss the role of type I receptors on BMP morphogen gradient formation, signaling in three different areas are assessed: the DPP expressing cells at the anterior-posterior compartment boundary (1), cells within the expression domains of sal and omb (2), and cells outside of the omb domain (3).
(1) TKV concentrations are particularly low in DPP expressing cells (Tanimoto et al., 2000) . Since TKV homodimers and SAX-TKV heterodimers are scarce, high levels of DPP can only moderately signal through primarily TKV-SAX heterodimers. Limited signaling of DPP in the DPP expressing cells is important, since high levels of signaling activates a negative feedback loop that down-regulates dpp expression (Haerry et al., 1998) . SAX homodimers, which are abundant in this area, do not contribute to signaling in these cells, because they do not bind DPP and have low or no signaling activity. The contribution of GBB to the activity gradient is also low, since the level of SAX-TKV heterodimers is low and significant amounts of GBB are bound by the abundantly present SAX homodimers. In support of this notion, a reduction of SAX levels has been shown to increase rather than decrease the domain of phosphorylated MAD in wing discs (Bangi and Wharton, 2006) .
(2) Increasing concentrations of SAX-TKV heterodimers within the sal domain partially offset decreasing concentrations of DPP. As DPP signaling diminishes, the contribution of GBB grows with rising levels of heterodimers. The combined activities of DPP and GBB signaling through heterodimers results in a shallow gradient that drops at the boundaries of sal. A role of GBB signaling within the sal domain is supported by the previous finding that sal expression is reduced in clones of sax mutants (Singer et al., 1997) . Without SAX, only TKV homodimers are present, and since GBB does not bind efficiently to TKV homodimers, GBB signaling is greatly reduced. While DPP signaling further decreases outside the sal domain, a surge in GBB activity through increased levels of SAX-TKV heterodimers maintains the expression of omb, which requires a lower threshold for activation than sal.
(3) Adjacent to the omb domain, TKV is expressed at high levels that allow the formation of TKV homodimers. With a high affinity for DPP, TKV homodimers likely prevents further diffusion of DPP. Thus, outside of the omb domain, the predominant activity is provided by GBB signaling through SAX-TKV heterodimers, since GBB does not efficiently bind to TKV homodimers. In summary, the existing data support a model, where, as the role of DPP decreases with distance from the compartment boundary, growth and patterning gradually more depends on GBB signaling through SAX-TKV heterodimers.
Activation of MAD by tetrameric BMP receptor complexes
Since over-expression of wild type SAX results in peripheral loss-of-function wing vein defects similar to clones of sax mutants, it was proposed that SAX homodimers sequester GBB into complexes with no signaling activity (Bangi and Wharton, 2006; Singer et al., 1997) . SAX-A can phosphorylate MAD at the C-terminus, although approximately at a 10-fold lower level than TKV1-A (Fig. 5) . While multiple copies of SAX-A fail to ectopically induce omb and sal expression ( Fig. 4E and F) , a single copy of SAX-A-K382T can ectopically activate the two genes ( Fig. 4H and I ). SAX-A-K382T phosphorylates MAD approximately three times more efficiently than SAX-A. However, the result that TKV1-A-T318D with a 3-fold higher activity than SAX-A-K382T fails to expand the expression of sal and omb suggests that the C-terminal phosphorylation level of SMADs is not the sole parameter that determines the threshold for downstream gene activation. In wings, expression of both TKV1-A-T318D and TKV1-A-T485D results in dominant-negative phenotypes due to DPP sequestration and lack of signaling ( Fig. 4M and P) . MAD that is ectopically phosphorylated by TKV1-A-T318D localized to the nucleus (Fig. 4T-V) , indicating that nuclear localization of SMADs is not sufficient for the regulation of downstream genes. Together, these findings imply that SMAD require a second activation step in addition to C-terminal phosphorylation.
The location of T318 and T485 implies that the residues could affect type I receptor dimerization (Huse et al., 1999) . In a dimer, T318 in the E6 loop of TKV is located very close to T485 in front of the C-terminal alpha helix of the second subunit (Fig. 3C) . However, mutations in these residues do not disrupt type I receptor dimerization, since SAX and mutant forms of SAX and TKV with aspartic acids at these locations are able to form homodimers in co-immunoprecipitation experiments (Fig. 1, unpublished data) . T318D is located next to G317, the position equivalent to the mutation G322D in the vertebrate TbRI, which was shown to prevent phosphorylation of TbRI by type II receptors (Weis-Garcia and Massague, 1996) . Thus, it is likely that the T318D substitution in TKV also interferes with type II receptors complex formation. This model is supported by the finding that, similar to complementation of the activation-defective TbRI-G322D by a kinase-inactive receptor form, SAX-A can enhance signaling of TKV1-A-T318D (Fig. 8C) . Taken together, these results indicate that mutations in the E6 loop and possibly in the C-terminal region of type I receptor homodimers can act in trans to impede assembly into an active configuration with type II receptors in a tetrameric signaling complex.
It was previously not examined, whether the mutant TbRI-G322D was able to physically interact with type II receptors. Co-immunoprecipitation experiments show that the ''inactive'' E6 loop mutant forms TKV1-A-T318D and SAX-A can form complexes with PUT (Fig. 7) that, however, fail to properly activate MAD and downstream genes (Fig. 4D-F and M-O) . In contrast, the single K382T mutation in SAX-A does not quantitatively enhance binding to PUT (Fig. 7 , lanes 5 and 6), but allows complete activation of MAD and downstream genes (Fig. 4G-I ). Taken together, these results suggest a model, where the nature of the E6 residue plays an important role in enhancing or preventing the assembly of tetrameric complexes into a configuration that can completely activate SMADs and downstream genes.
In contrast to the inactive TbRI-G322D receptors, the E6 loop mutant forms of SAX and TKV1 used in this study are constitutively activated forms that clearly exhibit phosphorylation activity. Since the activation mutations in TKV1-Q199D and SAX-Q263D are located at the end of the GS-box and do not involve the substitution of a serine or threonine, they likely do not mimic normal activation via GS-box phosphorylation at multiple serines by type II receptors. It was found that purified activated type I receptors do not phosphorylate SMADs in kinase assays (Hoodless et al., 1996) , indicating that the function of activated type I receptors may require the presence of type II receptors. Most likely, the pathway activating mutations in type I receptors allow ligand independent interactions with type II receptors. In S2 cells, type I and II receptors do not phosphorylate SMADs at physiological concentrations in the absence of ligands (Fig. 5, lane 1) , suggesting that the interaction of type I and II receptors is prevented by an unknown protein (complex). However, this inhibition can be overcome by over-expression of type II or non-activated type I receptors, resulting in SMAD phosphorylation in the absence of ligands (unpublished results). A requirement of type II receptors in MAD activation is also supported by experiments in animals with mutations in the type II receptor Wishful Thinking (WIT). The two type II receptors WIT and PUT are expressed in overlapping patterns in various tissues. Mutants in wit are paralyzed and die as pharate adults due to defects in neuromuscular junctions (Marques et al., 2002) . The lethality of wit mutants can be rescued by expression of two extracellular-intracellular chimeric WIT-TKV and TKV-WIT proteins , indicating that signaling through TKV is sufficient for neuronal function. However, expression of various levels of TKV-A in these neurons fails to rescue wit mutants, indicating that TKV-A does not signal properly in the absence of type II receptors.
Since C-terminal phosphorylation is not sufficient to activate MAD and co-expression of the type II receptor PUT but not activated forms of SAX can enhance the wing phenotypes of the C-terminally activated MAD-SDVD ( Figs. 4 and 6) , the question arises what the mechanism of a second activation step is. Since all components of tetrameric receptor complexes exhibit serine/threonine kinase activity, it is likely that MAD is phosphorylated at one or more serines or threonines in addition to the C-terminal serines. Consistent with this notion, the original reports that identified the C-terminal modifications of SMADs also described a second phospho-peptide (Kretzschmar et al., 1997) . At the time, it was speculated that the two peptides represent the phosphorylation of a single or multiple C-terminal serines, but the molecular nature of this posttranslational modification was never resolved. There are two possibilities for a two-step mechanism. In the active configuration, type II receptors activate type I receptors that subsequently phosphorylate SMADs at the C-terminus and at the second site(s). Alternatively, in addition to activation of type I receptors, type II receptors may directly phosphorylate SMADs at the alternate site(s). Since there are many conserved serines and threonines in SMADs, one can currently only speculate about which residues are likely targets for phosphorylation.
4.
Materials and methods
Constructs and generation of transgenic lines
For tissue culture assays, cDNAs were cloned into pAcpA, which contains the 2.5 kb Actin5C promoter and polyA regions (McCabe et al., 2003) . For expression in vivo, cDNAs were cloned into pUAST (Brand and Perrimon, 1993) and pUAST2 (Gesualdi and Haerry, 2007) . In this study, expression vectors for DPP, DPP-HA, GBB, GBB-HA, TKV1-HA and TKV1-FLAG, TKV2-HA and TKV2-FLAG, SAX-HA, and SAX-FLAG, PUT-FLAG, and FLAG-MAD were used. Receptor constructs with extracellular deletions were previously described in (Haerry et al., 1998) . While DPP and GBB were tagged internally after the processing sites, a single HA or FLAG tag was added at the C-terminus of all receptors. pUAST-lines that express constitutively active forms TKV1-Q199D and SAX-Q263D and the pseudo-activated MAD-SDVD were described in previous reports (Gesualdi and Haerry, 2007; Haerry et al., 1998; Hoodless et al., 1996) . Various amino acid sequence alterations were performed using the Quikchange protocol from Stratagene. All pUAST constructs were injected at a concentration of 1.5 lg/ll and 0.5 lg/ll of D2-3 helper plasmid. Details about individual constructs are available upon request.
Analysis of transgenic fly strains
In this study, several transgenic insertion lines were generated and analyzed for each construct. The transgenes were induced with A9-GAL4 at 25°C (Haerry et al., 1998) .
Tissue cultures assays
The procedure of the signaling assay was previously described (McCabe et al., 2003) . In these experiments, 1 · 10 7 Schneider 2 (S2) cells were co-transfected with 1 lg of pAcpA-DNAs of TKV-A and SAX-A and 1 lg of FLAG-MAD. For co-immunoprecipitation experiments, 4 · 10 7 cells transfected with 10 lg of pAcpA-DNAs of FLAG-tagged receptors were collected after 3 days and mixed with supernatants from 4 · 10 7 cells transfected with 10 lg of pAcpA-DNAs of HAtagged ligands. After one hour, the mixture was incubated with 10 ll of anti-FLAG beads (Sigma A2220). The beads were collected in spin columns and washed six times with TTBS. The bound material was released from the beads with 1x SDS loading buffer and analyzed on Western blots. To compare P-MAD levels in Fig. 5 , the density and size of each lane was measured using photo-imaging software and compared to lane 2.
Immuno-histochemistry and fluorescence
HA-tagged proteins were detected with anti-HA-biotin antibodies from Roche (11666851001) and the ABC kit from Vector (PK-6102). LacZ expression was monitored with anti-b-GAL monoclonal antibodies (Promega Z3781, 1:1000) and AP-coupled secondary antibodies (Promega S3721 and S3731) using an AP-substrate kit from Vector (SK-5400). C-terminal phosphorylation of MAD was detected with the anti-PS1 antibody (Persson et al., 1998) or an anti-human SMAD3 antibody that cross-reacts with Drosophila P-MAD (Sun et al., 2007) . To determine subcellular localization of P-MAD, stainings of secondary fluorescent Alexa555 antibodies (Invitrogen A31629) were captured with a Nikon confocal microscope.
